Proteomics

Dataset Information

0

Proteomic interrogation of the cell envelope of Neisseria gonorrhoeae exposed to physiologically relevant environmental cues.


ABSTRACT: Gonorrhea occurs at high incidence worldwide and has a major impact on reproductive and neonatal health worldwide. Alarmingly, with each new antibiotic introduced for gonorrhea, resistance has emerged, including resistance to penicillin, tetracycline, fluoroquinolones, and recently the third-generation cephalosporins. Treatment options are currently seriously limited and the development of a gonorrhea vaccine is a critical, longterm solution to this problem. Progress on gonorrhea vaccines has been slow, however, in part due to the high number of surface molecules in Neisseria gonorrhoeae (GC) that undergo phase or antigenic variation and a lack of understanding of protective responses. Gonorrhea vaccine development can therefore benefit from a comprehensive, unbiased approach for antigen discovery. Here we identified cell envelop proteins from Neisseria gonorrhoeae exposed to physiology relevant conditions: presence of human serum, iron limitation and anaerobic growth.

INSTRUMENT(S): LTQ Orbitrap Elite

ORGANISM(S): Neisseria Gonorrhoeae (strain Atcc 700825 / Fa 1090)

TISSUE(S): Prokaryotic Cell

DISEASE(S): Gonorrhea

SUBMITTER: Aleksandra Sikora  

LAB HEAD: Aleksandra Sikora

PROVIDER: PXD001944 | Pride | 2016-05-09

REPOSITORIES: Pride

altmetric image

Publications

Proteomics-driven Antigen Discovery for Development of Vaccines Against Gonorrhea.

Zielke Ryszard A RA   Wierzbicki Igor H IH   Baarda Benjamin I BI   Gafken Philip R PR   Soge Olusegun O OO   Holmes King K KK   Jerse Ann E AE   Unemo Magnus M   Sikora Aleksandra E AE  

Molecular & cellular proteomics : MCP 20160502 7


Expanding efforts to develop preventive gonorrhea vaccines is critical because of the dire possibility of untreatable gonococcal infections. Reverse vaccinology, which includes genome and proteome mining, has proven very successful in the discovery of vaccine candidates against many pathogenic bacteria. However, progress with this approach for a gonorrhea vaccine remains in its infancy. Accordingly, we applied a comprehensive proteomic platform-isobaric tagging for absolute quantification couple  ...[more]

Similar Datasets

2019-03-13 | PXD008673 | Pride
2006-12-13 | E-MEXP-514 | biostudies-arrayexpress
2012-06-15 | E-MEXP-3258 | biostudies-arrayexpress
2007-04-04 | E-TIGR-129 | biostudies-arrayexpress
2012-06-15 | E-MEXP-3256 | biostudies-arrayexpress
2012-06-15 | E-MEXP-3257 | biostudies-arrayexpress
2018-12-07 | GSE123434 | GEO
2018-12-19 | PXD008412 | Pride
2020-03-10 | GSE146622 | GEO
2009-09-15 | GSE16046 | GEO